EYE National Vision Holdings, Inc.

Q3 2025 10-Q
Filed: Nov 6, 2025Period ending Sep 27, 2025
Health Care
Ophthalmic GoodsSEC EDGAR

National Vision Holdings, Inc. (EYE) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Nov 6, 2025 for the fiscal period ending Sep 27, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q3 2025 10-Q

Risk Factors

  • No newly added risk factors disclosed; risk section largely unchanged from 10-K
  • Updated operational risk: plan to open ~32 new stores in FY2025 targeting incremental free cash flow generation amid changing store opening cadence
+3 more insights

Quarterly Financial Summary
XBRL

Revenue

$487M

+7.9% YoY +0.2% QoQ

Net Income

$3M

+139.8% YoY -61.4% QoQ

Operating Margin

2.0%

+393bp YoY -141bp QoQ

Net Margin

0.7%

+257bp YoY -110bp QoQ

ROE

0.4%

Total Assets

$2.0B

EPS (Diluted)

$0.04

+136.4% YoY -63.6% QoQ

Operating Cash Flow

$47M

+67.0% YoY -14.1% QoQ

Source: XBRL data from National Vision Holdings, Inc. Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.

Get deeper insights on National Vision Holdings, Inc.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.